Clinical Trials Sponsored by Herzzentrum Goettingen

Total 284 results

Herzzentrum Goettingen

Completed

Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation

Heart Failure | Shock, Cardiogenic | Acute Myocardial Infarction

Germany
Herzzentrum Goettingen
University of Göttingen; Medical Statistics, University Medicine of Goettingen and other collaborators

Completed

Placebo-Controlled Crossover Study for the Investigation of the Effect of Pantoprazole on Cardiac Contractility (HIPPO)

Healthy

Germany
University of Göttingen
University Medical Center Goettingen

Unknown

Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit

Systemic Lupus Erythematosus | Vasculitis | Myositis

Germany
Herzzentrum Bremen

Withdrawn

Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency (IronEx)

Exercise Training | Heart Failure With Reduced Ejection Fraction | Ferric Carboxymaltose

Germany
Herzzentrum Bremen

Recruiting

New Technologies for Intensive Prevention Programs - NET-IPP (NET-IPP)

Coronary Artery Disease

Germany
Herzzentrum Coswig

Completed

Does MiECC Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?

Acute Kidney Injury
University Hospital Goettingen

Completed

Evaluation of Coagulation Factors and Point-of-care Devices During Veno-venous ECMO Therapy

Extracorporeal Membrane Oxygenation Complication | Coagulation Factor Deficiency

Germany
Deutsches Herzzentrum Muenchen

Recruiting

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry (OBSERV-MITRA)

Mitral Valve Stenosis | Mitral Valve Regurgitation | Tricuspid Valve Regurgitation

Germany
Deutsches Herzzentrum Muenchen

Completed

High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation

Paroxysmal Atrial Fibrillation

Germany
Deutsches Herzzentrum Muenchen

Completed

TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation (TROPIC)

Sudden Cardiac Death

Germany
Deutsches Herzzentrum Muenchen

Completed

Safe Traction During Ongoing Lead Extraction Procedure (STOP) (STOP)

Electrode Malfunction | Infections of Cardiac Electronic Implantable Devices

Germany
Deutsches Herzzentrum Muenchen

Unknown

4D- Flow- MRI After Aortic Valve Surgery

Aortic Valve Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES (ISAR-DESIRE 3A)

Coronary Restenosis

Germany
Deutsches Herzzentrum Muenchen

Unknown

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction (ISAR-Absorb MI)

Myocardial Infarction | Cardiovascular Disease | Thrombus | Primary Angioplasty

Germany
Deutsches Herzzentrum Muenchen

Completed

Treatment Satisfaction in Implantable Cardioverter Defibrillator Recipients (SAN REMO 2)

Improvement of Treatment Satisfaction

Germany
Deutsches Herzzentrum Muenchen

Completed

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery

Myocardial Infarction

Germany
Deutsches Herzzentrum Muenchen

Completed

Safety of Screening Procedures With Hand-held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices

Electromagnetic Interference

Germany, Greece
Deutsches Herzzentrum Muenchen

Completed

Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial (ISAR-CLOSURE)

Coronary Artery Disease

Germany
Deutsches Herzzentrum Muenchen

Terminated

Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-2)

Atherosclerosis | Atrial Fibrillation | Coronary Heart Disease | Acute Coronary Syndrome

Germany
Deutsches Herzzentrum Muenchen

Unknown

Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction (BRAVE-4)

Myocardial Infarction

Germany
Deutsches Herzzentrum Muenchen

Unknown

Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing (ISAR ADAPT PF)

Coronary Heart Disease

Germany, Hungary
Deutsches Herzzentrum Muenchen

Unknown

The TAKO-TSUBO And Cancer Registry (TTAC)

Acute Coronary Syndrome | Tako-Tsubo Cardiomyopathy | Stress-induced Cardiomyopathy

Germany
Deutsches Herzzentrum Muenchen

Unknown

Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation

Paroxysmal Atrial Fibrillation | Ablation

Germany
Deutsches Herzzentrum Muenchen

Unknown

Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation (REDO-AF)

Recurrence | Atrial Fibrillation

Germany
Deutsches Herzzentrum Muenchen

Completed

Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome (ISAR-REACT-4)

Myocardial Infarction | Coronary Disease

Germany, Italy
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents (DESIRE-2)

Coronary Artery Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)

Coronary Disease | Angina Pectoris

Germany
Deutsches Herzzentrum Muenchen

Unknown

Line Versus Spot Ablation in Persistent Atrial Fibrillation

Atrial Fibrillation

Germany
Deutsches Herzzentrum Muenchen

Completed

Oral Sirolimus for In-Stent Restenosis (OSIRIS)

Coronary Restenosis

Germany
Deutsches Herzzentrum Muenchen

Completed

Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation

Atrial Fibrillation

Germany
Deutsches Herzzentrum Muenchen

Completed

Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)

Coronary Disease

Germany
Deutsches Herzzentrum Muenchen

Recruiting

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation (ACCESS-TAVI)

Aortic Valve Stenosis

Germany
Deutsches Herzzentrum Muenchen

Recruiting

The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation. (AF GEN)

Atrial Fibrillation

Germany
Deutsches Herzzentrum Muenchen

Recruiting

PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device (PROTECT)

Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves

Germany
Deutsches Herzzentrum Muenchen

Recruiting

Anesthesia for Catheter Aortic Valve ImplantATIOn Registry (AVIATOR)

Heart Failure | Anesthesia | Failed Conscious Sedation During Procedure | Critical Incident | Excessive Amount of Blood / Fluid Transfusion | Intraoperative Cardiac Arrest During Cardiac Surgery

Germany
Deutsches Herzzentrum Muenchen

Completed

Myocardial Minimal Damage After Rapid Ventricular Pacing (MyDate)

Antitachycardia Pacing

Germany
Deutsches Herzzentrum Muenchen

Active, not recruiting

Contemporary Transvenous Lead Extraction Outcomes (TLE)

Endocarditis Infective | ICD | Pacemaker Electrode Infection | Pacemaker Lead Dysfunction

Germany
Deutsches Herzzentrum Muenchen

Completed

Validation of Procalcitonin as a Biomarker Diagnosing CDI ((DIRT II))

Cardiac Implantable Electronic Device Infections
Deutsches Herzzentrum Muenchen

Completed

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction

Infarction, Myocardial

Germany
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis (ISAR-DESIRE-3)

Ischemia | Heart Disease | Restenosis

Germany
Deutsches Herzzentrum Muenchen

Unknown

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE)

Coronary Artery Disease | Atrial Fibrillation

Denmark, Germany
Deutsches Herzzentrum Muenchen

Terminated

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation (ISAR-CAUTION)

Coronary Artery Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (FULL CONTACT)

Improving Outcome After Pulmonary Vein Isolation

Germany
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy With Bioresorbable Polymer Coating Versus Bioresorbable Polymer Backbone (ISAR-RESORB)

Coronary Stenosis

Germany
Deutsches Herzzentrum Muenchen

Completed

Safety of Smartphones Among Patients With Cardiac Implantable Electronic Devices

Recipients of Implantable Pacemakers or Defibrillators

Germany
Deutsches Herzzentrum Muenchen

Unknown

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE)

Coronary Artery Disease

Germany, Denmark, New Zealand, Japan, Belgium, Switzerland, United States, Albania, Austria, China, Ireland, Italy, Netherlands
Deutsches Herzzentrum Muenchen

Unknown

Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease (ISAR-STATH)

Peripheral Vascular Diseases

Germany
Deutsches Herzzentrum Muenchen

Completed

Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-1)

Atrial Fibrillation

Germany
Deutsches Herzzentrum Muenchen

Completed

Copeptin in Aortic Valve Replacement (CARE)

Copeptin in Patients Undergoing Aortic Valve Replacement

Germany

Clinical Trials Sponsored by Herzzentrum Goettingen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations